Seaview Investment Managers LLC Regeneron Pharmaceuticals, Inc. Transaction History

Seaview Investment Managers LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$595.12 - $698.43 $6.75 Million - $7.93 Million	-11,349 Closed	0 $0
Q4 2021 Feb 04, 2022	BUY	$543.48 - $670.97 $6.17 Million - $7.61 Million	11,349 New	11,349 $7.17 Million
Q2 2021 Jul 30, 2021	SELL	$472.8 - $558.54 $3.52 Million - $4.16 Million	-7,443 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$446.73 - $548.2 $367,658 - $451,168	823 Added 12.43%	7,443 $3.52 Million
Q4 2020 Feb 05, 2021	BUY	$478.3 - $607.98 $458,211 - $582,444	958 Added 16.92%	6,620 $3.2 Million
Q3 2020 Nov 20, 2020	BUY	$544.75 - $658.21 $3.08 Million - $3.73 Million	5,662 New	5,662 $3.08 Million

1,496

82.9M

1.22M

1.5M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Seaview Investment Managers LLC, based on Form 13F filings with the SEC.

Stay updated on Seaview Investment Managers LLC with notifications on news.